Rosetta Genomics Ltd. Increase (Decrease) in Deferred Revenue
Rosetta Genomics Ltd. reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2016-12-31, per its 6-K filed 2017-10-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-10-10
| Period end | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|
| 2016-12-31 | $0.00 6-K · filed 2017-10-10 |
| 2015-12-31 | $0.00 6-K · filed 2017-10-10 |
| 2014-12-31 | -$228.00K 6-K · filed 2017-10-10 |
| 2011-12-31 | $0.00 6-K · filed 2012-12-07 |
| 2010-12-31 | -$1.70M 20-F · filed 2013-03-22 |
| 2009-12-31 | $1.70M 6-K · filed 2012-12-07 |